Clinical Study of Huangqi Danshen Drop Pill for Angina Pectoris Due to Coronary Heart Disease
- VernacularTitle:黄芪丹参滴丸治疗冠心病心绞痛的临床研究
- Author:
Qiong ZHANG
;
Lizhi LI
;
Xiuhua TU
- Publication Type:Journal Article
- Keywords:
Huangqi Danshen Drop Pill;
Angina pectoris due to coronary heart disease;
TCD therapy
- From:
Traditional Chinese Drug Research & Clinical Pharmacology
1993;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the therapeutic effect and safety of Huangqi Danshen Drop Pill (HDP) for angina pectoris (AP) due to coronary heart disease (CHD) classified as qi- deficiency and blood- stasis syndrome. Methods A multi- center, randomized, double- blind, double- simulation, positive- controlled, parallel group trial was adopted. 209 cases of AP due to CHD classified as qi- deficiency and blood- stasis syndrome were enrolled in this study: 104 in HDP group and 105 in Yangxinshi Tablets group. Results The markedly effective rate was 43.27 % , total effective rate 86.53 % , and total effective rate in improving TCM symptoms 92.31 % in HDP group, which were better than those in Yangxinshi Tablets group(P
